Form 4: Concentrix Executive Sells 500 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Cormac J. Twomey, an EVP at Concentrix, sold 500 shares of common stock at $44.05 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Cormac J. Twomey, an Executive Vice President at Concentrix, sold 500 shares of the company's common stock on December 30, 2024.
- The sale was executed at a price of $44.05 per share.
- This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted by Mr. Twomey on January 29, 2024.
- Following the sale, Mr. Twomey directly owns 23,936 shares of Concentrix common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to an executive stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment about the company's performance or future prospects.
Industry Context
This is a routine filing related to insider trading activity and is common for executives of publicly traded companies. The use of a 10b5-1 plan indicates a pre-planned sale, which is a common practice to avoid accusations of trading on inside information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including competitors like Teleperformance and TaskUs.
- These plans allow executives to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
- The volume of shares sold (500) is relatively small compared to the total shares held by the executive (23,936), suggesting this is a routine transaction rather than a significant divestment.
Stakeholder Impact
- The sale of shares by an executive may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan suggests it was a planned transaction and not a reaction to any specific company news.
Key Dates
| Date | Description |
|---|---|
| 01/29/2024 | Date the 10b5-1 trading plan was adopted by Cormac J. Twomey. |
| 12/30/2024 | Date of the stock sale transaction. |
| 12/31/2024 | Date the Form 4 was signed. |
Keywords
Concentrix, insider trading, Form 4, stock sale, Rule 10b5-1, executive, CNXC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.